Article
Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Jul 1993
Sun Y, Dong Z, Nakamura K, Colburn N H
Abstract excerpt
Mutational inactivation of p53, a tumor suppressor gene, is the most common genetic alteration found in human cancer. Most mutated p53s either lose tumor suppressor function or gain oncogenic activity. We recently reported the detection of a heterozygous point mutation of p53 at codon 280 in nasopharyngeal carcinoma (NPC) (1), a high-incidence malignancy in southern China and southeast Asia. Given its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
